MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells

Marlies J W Peeters1, Donata Dulkeviciute2, Arianna Draghi2

  • 1Department of Hematology, Center for Cancer Immune Therapy, University Hospital Herlev, Copenhagen, Denmark. per.thor.straten@regionh.dk marlies.peeters@regionh.dk.

Insights

Activated CD8+ T cells express MERTK, a receptor tyrosine kinase, which enhances their proliferation and cytokine secretion. This MERTK signaling also boosts tumor-infiltrating lymphocytes in melanoma, suggesting caution with MERTK inhibitors.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • TAM receptor tyrosine kinases (TYRO3, AXL, MERTK) are involved in immune regulation and cancer.
  • CD8+ T cells were previously thought to lack TAM receptor expression.

Purpose of the Study:

  • To investigate the expression and function of TAM receptors, specifically MERTK, in activated human CD8+ T cells.
  • To determine the role of MERTK signaling in T cell responses and anti-tumor immunity.

Main Methods:

  • T-cell receptor activation of primary human CD8+ T cells.
  • Analysis of MERTK and PROS1 expression post-activation.
  • Knockdown and inhibition studies to assess MERTK function.
  • Transcriptomic and metabolic analyses.
  • Studies using tumor-infiltrating lymphocytes (TIL) from melanoma patients.

Main Results:

  • TCR-activated human CD8+ T cells express MERTK and its ligand PROS1.
  • PROS1-mediated MERTK signaling acts as a late costimulatory signal, enhancing T cell proliferation and cytokine production.
  • MERTK signaling is crucial for memory CD8+ T cell differentiation.
  • MERTK signaling on T cells improves TIL expansion and cancer cell killing in melanoma.

Conclusions:

  • MERTK functions as a late costimulatory signal for human CD8+ T cells.
  • The PROS1-MERTK axis plays a significant role in T cell immunity and anti-tumor responses.
  • Targeting MERTK warrants caution due to its beneficial role in T cell function and anti-cancer immunity.

Related Concept Videos

Forces Acting on Chromosomes02:11

Forces Acting on Chromosomes

During mitosis, chromosome movements occur through the interplay of multiple piconewton level forces. In prometaphase, these forces help in chromosome assembly or congression at the equatorial plane, eventually leading to their alignment at the metaphase plate. The forces acting on the chromosomes are space and time-dependent; therefore, they vary with the position of the chromosomes as the cell progresses through mitosis. 
Microtubules and motor proteins exert two types of forces on...
3.9K
Types of Receptors: Cell Surface Receptors01:28

Types of Receptors: Cell Surface Receptors

Cell-surface receptors, also known as transmembrane receptors, are cell surface, membrane-anchored (integral) proteins that bind to external ligand molecules. This type of receptor spans the plasma membrane and performs signal transduction, converting an extracellular signal into an intracellular signal. Ligands that interact with cell-surface receptors do not have to enter the cell that they affect. Cell-surface receptors are also called cell-specific proteins or markers because they are...
26.8K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.3K
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.8K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.1K
Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.6K